Literature DB >> 25110876

Hematopoietic stem cell transplantation of an adolescent with neurological manifestations of homozygous missense PRF1 mutation.

Ayad Ahmed Hussein1, Tuka Hamadah, Monther Qandeel, Maher Sughayer, Rula Amarin, Asem Mansour, Samuel C Chiang, Abdulhadi Al-Zaben, Marie Meeths, Yenan T Bryceson.   

Abstract

Individuals with biallelic truncating PRF1 mutations typically present with fulminant early-onset familial hemophagocytic lymphohistiocytosis (FHL). We report a 19-year-old male with a 5-year history of recurrent fever and headaches progressing to refractory seizures. Brain imaging revealed multiple ring enhancing lesions. Laboratory investigations demonstrated that the patient displayed defective lymphocyte cytotoxicity and carried a homozygous missense PRF1 mutation, c.394G > A (p.Gly132Arg). The patient was successfully treated with chemo-immunotherapy followed by matched related allogeneic hematopoietic stem cell transplantation (HSCT). Our findings demonstrate that prompt HSCT of late-onset FHL with primarily neurological manifestation can reverse central nervous system symptoms and improve long-term outcome.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  HSCT; hemophagocytic lymphohistiocytosis; late onset; primary immunodeficiency

Mesh:

Substances:

Year:  2014        PMID: 25110876     DOI: 10.1002/pbc.25166

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  3 in total

Review 1.  Current Flow Cytometric Assays for the Screening and Diagnosis of Primary HLH.

Authors:  Samuel Cern Cher Chiang; Jack J Bleesing; Rebecca A Marsh
Journal:  Front Immunol       Date:  2019-07-23       Impact factor: 7.561

2.  RF1 Gene Mutation in Familial Hemophagocytic Lymphohistiocytosis 2: A Family Report and Literature Review.

Authors:  Yuan Shi; Zhidong Qiao; Xiaoduo Bi; Chenxin Zhang; Junxian Fu; Yuexin Jia; Guanglu Yang
Journal:  Pharmgenomics Pers Med       Date:  2021-12-16

Review 3.  Neuroinflammation Associated With Inborn Errors of Immunity.

Authors:  Hannes Lindahl; Yenan T Bryceson
Journal:  Front Immunol       Date:  2022-01-19       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.